Helius Medical Technologies, Inc.

HSDT

3 Followers
$4.30 +3.12% $0.13
11 August
Upcoming Earnings
 
Market Cap.
 
P/E
Loading...

My Notes

Začít psát

Profile

Helius Medical Technologies, Inc. is a biopharmaceutical company focused on the development and commercialization of neurostimulation therapies for the treatment of neurological disorders. Its main product platform is the Portable Neuromodulation Stimulator (PoNS) technology, which utilizes tongue stimulation to influence brain function and the nervous system. This technology has the potential to help patients with various neurological disorders, including traumatic brain injury, multiple sclerosis, and other neurological conditions. The company focuses on conducting clinical trials and obtaining regulatory approvals for its therapeutic products. Its goal is to provide innovative and effective treatment methods to improve the quality of life for patients suffering from neurological disorders. Shares of Helius Medical Technologies, Inc. may be an interesting investment opportunity for investors following the biopharmaceutical industry and neurological medicine.

Feed

There are no posts to show right now.
Don't have an account? Join us

Log in to Bulios


Or use email and password
Already a member? Log in

Create Bulios profile

Continue with

Or use email and password
You can use lowercase letters, numbers, and underscores

Why Bulios?

One of the fastest growing investor communities in Europe

Comprehensive data on thousands of stocks from around the world

Current information from global markets and individual companies

Education and exchange of investment experience among investors

Fair prices, portfolio tracker, stock screener and other tools

Menu StockBot
Tracker
Upgrade